Echocardiographic data Overall (N=50) RVD (N=12) Control (N=38) p-value
LV-EF (%) 43.65 ± 11.7 43.18 ± 12.5 43.78 ± 11.7 0.86
RVSP (mmHg) 38.0 ± 14.5 48.2 ± 9.0 33.36 ± 14.3 P<0.01
TAPSE (mm) 22.09 ± 5.5 14.86 ± 3.5 23.96 ± 4.2 P<0.01
Grade of TI 1.03 ± 0.7 1.77 ± 0.6 0.83 ± 0.6 P<0.01
Laboratory data
Creatinekinase-MB (μkat/L) 2.95 ± 3.0 3.32 ± 3.4 2.84 ± 2.8 0.34
pH at admission 7.39 ± 0.09 7.37 ± 0.08 7.39 ± 0.09 0.41
Lactatmmol/L 2.37 ± 2.2 2.81 ± 2.9 2.23 ± 2.0 0.45
Blood glucose mmol/L 8.5 ± 3.9 10.31 ± 4.7 7.84 ± 3.4 0.076
Creatinin μmol/L 121.3 ± 74.4 162.9 ± 137 107.8 ± 29.2 P<0.05
GFR (ml/min/m2) 59.2 ± 22.6 41.9 ± 25.9 65.0 ± 18.4 P<0.05
ASAT (μkat/L) 5.57 ± 13.1 10.29 ± 22.9 3.84 ± 6.7 0.17
ALAT (μkat/L) 2.46 ± 7.1 5.23 ± 12.8 1.44 ± 2.5 0.13
Platelets (109/L) 216.3 ± 72.2 179.5 ± 89.4 228.0 ± 63.6 0.45
Hemoglobin (mmol/L) 7.79 ± 1.5 7.4 ± 1.0 7.9 ± 1.6 0.31
Cholesterol (mmol/L) 4.18 ± 1.45 3.75 ± 1.85 4.29 ± 1.37 0.47
Table 2: Clinical characteristics at admission.